Blackbaud Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.1B-0.6% YoYTTM through 30 Jun 2026
Net Income $150.7MTTM through 30 Jun 2026
Free Cash Flow $329.2MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 58.8% |
| EBITDA Margin | 27.1% |
| Operating Margin | 16.9% |
| Net Margin | 13.1% |
Returns
135.2%ROE
4.8%ROA
12.7%ROIC
Balance Sheet Health
Debt / Equity12.78x
Current Ratio0.64x
Net Debt$1B
Cash & Equivalents$34.4M
Quality Metrics
Altman Z-Score1.12
Piotroski F-Score8 / 9
FCF Margin28.7%
Rule of 4031.2
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $1.1B
Diluted EPS$3.20TTMFY2025: $2.37
Dividend
$0.12Per share, FY20200.00%Yield
Capital Allocation
R&D Spend$142.7M
Capex Intensity0.9%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Contractual Recurring | $722.2M | View detailsExpected to benefit from standard three-year contracts with embedded annual price increases. | |
| Transactional Recurring | $383.7M | View detailsDriven by donation processing, consumer giving, and tuition management. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.